Renalytix Plc (AIM:RENX)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 5.35
-0.20 (-3.59%)
Nov 6, 2026, 4:20 PM GMT
Renalytix Market Cap
Renalytix has a market cap or net worth of 32.31 million as of November 6, 2026. It is the 30,876th most valuable company in the world and the 683rd biggest in the United Kingdom. Its market cap has increased by 1.98% in one year.
Market Cap
32.31M
Enterprise Value
35.55M
Revenue
2.26M
Global Rank
Country Rank
#683 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 32.31M, a decrease of -49.97%. That is a compound annual growth rate of -8.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 33.21M | 28.80% |
| Dec 31, 2025 | 25.78M | -27.58% |
| Dec 31, 2024 | 35.60M | 129.87% |
| Dec 29, 2023 | 15.49M | -71.47% |
| Dec 30, 2022 | 54.30M | -87.89% |
| Dec 31, 2021 | 448.32M | 27.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.52B |
| GSK plc | 75.77B |
| Haleon | 29.74B |
| Smith & Nephew | 9.96B |
| MedPal AI | 39.08M |
| hVIVO | 37.79M |
| BATM Advanced Communications | 37.41M |
| Shield Therapeutics | 37.06M |